Detection of Isolated Tumor Cells by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism for K-ras Mutations in Tissue Samples of 199 Colorectal Cancer Patients

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 641-650

  Dieterle, Christoph P ^a   Conzelmann, Michael ^a   Linnemann, Ulrich ^b   Berger, Martin R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Municipal Hospital Nurnberg Nord   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLYCINE; SERINE;

ADULT; AGED; ALLELE; ARTICLE; BONE MARROW; CANCER PATIENT; CANCER TISSUE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PARAMETER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; STANDARD; TISSUE SLICE; TUMOR CELL; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BONE MARROW; CARCINOMA; CELL LINE, TUMOR; CODON; COLON; COLORECTAL NEOPLASMS; DNA; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHIDIUM; FEMALE; GENES, RAS; HETEROZYGOTE; HUMANS; LIVER; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; PROSPECTIVE STUDIES; RECTUM; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 0842289998     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1355-02     Document Type: Article

References (37)

1. rd Edition, pp. 160-188. Heidelberg: Springer, 1998.
2. Weitz, J., Koch, M., Lehnert, Th., Herfarth, Ch., and von Knebel Doeberitz, M. Detection of isolated disseminated tumor cells of colorectal cancer in lymph nodes. Der Chirurg, 71: 410-416, 2000.
3. Vogel, I., and Kalthoff, H., Disseminated tumor cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch., 439: 109-117, 2001.
4. Greenson, J. K., Isenhart, C. E., Rice, R., Mojzisik, C., Houchens, D., and Martin, E. W. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer (Phila.), 73: 563-569, 1994.
5. Liefers, J. G., Cleton-Jansen, A. M., van der Velde, C. J. H., Hermans, J., van Krieken J. H. J. M., Cornelisse, C. J., and Tollenaar, R. A. E. M. Micrometastases and survival in stage II colorectal cancer. N. Eng. J. Med., 339: 223-228, 1998.
6. Isaka, N., Nozue, M., Doy, M., and Fukao, K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM 5.2. Clin. Cancer Res., 5: 2065-2068, 1999.
7. Öberg, A., Stenlin, R., Tavelin, B., and Lindmark, G. Are lymph node micrometastases of any clinical significance in Dukes A and B colorectal cancer? Dis. Colon Rectum, 41: 1244-1249, 1998.
8. Cutait, R., Alves, V. A. F., Lopes, L. C., Cutait, D. E., Borges, J. L. A., Singer, J., da Silva, J. H., and Goffi, F. S. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum, 34: 917-920, 1991.
9. Adell, G., Boeryd, B., Franlund, B., Sjödahl, R., and Hakansson, L. Occurence and importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcnoma: an immunohistochemical study. Eur. J. Surg., 162: 637-642, 1996.
10. Broll, R., Schauer, V., Schimmelpenning, H., Strik, M., Strik, M., Woltmann, A., Best, R., Bruch, H. P., and Duchrow, M. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas. Dis. Colon Rectum, 40: 1465-1471, 1997.
11. Jeffers, M. D., O'Dowd, G. M., Mulcahy, H., Stagg, M., O'Donoghue, D. P., and Toner, M. The prognostic significance of immunohistochemically detected lymph nodes micrometastases in colorectal carcinoma. J. Pathol., 172: 183-187, 1994.
12. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
13. Tobi, M., Luo, F-C., and Ronai, Z. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Nat. Cancer Inst., 86: 1007-1010, 1994.
14. Norheim-Andersen, S., Breivik, J., Lovig, T., Meling, G. I., Gaudemack, G., Clausen, O. P., Schjolberg, A., Fausa, O., Langmark, F., Lund, E., and Rognum, T. O. K-ras mutations and HLA-DR expression in large bowel adenomas. Br. J. Cancer, 74: 99-108, 1996.
15. Moerkerk, P., Arends, J. W., van Driel, M., de Bruine, A., de Goeij, A., and ten Kate, J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res., 54: 3376-3378, 1994.
16. Kato, M., Ito, Y., Kobayashi, S., and Isono, K. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence. Cancer (Phila.), 77: 1729-1735, 1996.
17. Lee, J. C., Wang, S. T., Lai, M. D., Lin, Y. J.; and Yang, H. B. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res., 16: 3839-3844, 1996.
18. Kressner, U., Bjorheim, J., Westring, S., Wahlberg, S. S., Pahlman, L., Glimelius, B., Lindmark, G., Lindblom, A., and Borresen-Dale, A. L. Ki-ras mutations and prognosis in colorectal cancer. Eur. J. Cancer, 34: 518-521, 1998.
19. Pajkos, G., Kiss, I., Sandor, J., Ember, I., and Kishazi, P. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer. Anticancer Res., 20: 1695-1702, 2000.
20. Font, A., Abad, A., Monzo, M., Sanchez, J., Guillot, M., Manzano, J., Pinol, M., Ojanguren, I., and Rosell, R. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis. Colon Rectum, 44: 549-557, 2001.
21. Norheim-Andersen, S., Lovig, T., Breivik, J., Lund, E., Gaudernack, G., Meling, G. I., and Rognum, T. O. K-ras mutations and prognosis in large-bowel carcinomas. Scand. J. Gastroenterol., 32: 62-69, 1997.
22. Andreyev, H. J. N., Tilsed, J. V. T., Cunningham, D., Sampson, S. A., Norman, A. R., Schneider, H. J., and Clarke, P. A. K-ras mutations in Patients with early colorectal cancers. Gut, 41: 323-329, 1997.
23. De Kok, J. B., Swinkels, D. W., and Ruers, T. J. Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases. Anticancer Res., 20: 2469-2472, 2000.
24. Schimanski, C. C., Linnemann, U., and Berger, M. R. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res., 59: 5169-5175, 1999.
25. Brüderlein, S., van der Bosch, K., Schlag, P., and Schwab, M. Cytogenetics and DNA amplification in colorectal cancers. Genes Chromosomes Cancer, 2: 63-70, 1990.
26. Dunn, O. J. Multiple comparison using rank sums. Technometrics, 6: 241-252, 1964.
27. Stein, T. N., and Berger, M. R. Quantification of liver metastases from LS174T human colorectal cancer cells in nude rats by PCR. Anticancer Res., 19: 3939-3946, 1999.
28. Hermanek, P. Disseminated tumor cells versus micrometastasis: Definitions and problems. Anticancer Res., 19: 2771-2774, 1999.
29. Tortola, S., Steinert, R., Hantschick, M., Peinado, M. A., Gastinger, I., Stosiek, P., Lippert, H., Schlegel, W., and Reymond, M. A. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J. Clin. Oncol., 19: 2837-2843, 2001.
30. Etoh, T., Ureo, H., Inoue, H., Sato, K., Utsunomiya, T., Barnard, G. F., Kitano, S., and Mori, M. Clinical significance of K-ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma. Ann. Surg. Oncol., 8: 407-412, 2001.
31. Barbera-Guillem, E., Smith, I., and Weiss, L. Cancer cell traffic in the liver. I. Growth kinetics of cancer cells after portal-vein delivery. Int. J. Cancer, 52: 974-977, 1992.
32. Thebo, J. S., Senagore, A. J., Krygier, S., and Luchtefeld, M. A. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells. Am. Surg., 67: 802-805, 2001.
33. Ross, P. J., George, M., Cunningham, D., DiStefano, F., Jervoise, H., Andreyev, N., Workman, P., and Clarke, P. A. Inhibition of Kirstenras Expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides. Mol. Cancer Ther., 1: 29-41, 2001.
34. Andreyev, H. J., Norman, A. R., Cunningham, D., Oates, J. R., and Clarke, P. A. Kirsten ras mutations in patients with colorectal cancer: The multicenter "Rascal" study. J. Nat. Cancer Inst., 90: 675-684, 1998.
35. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
36. Morinello, E. J., Koc, H., Ranasinghe, A., and Swenberg, J. A. Differential induction of N2, 3-Ethenoguanine in rat brain and liver after exposure to vinyl chloride. Cancer Res., 62: 5183-5188, 2002.
37. Barbin, A. Etheno-adducts-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res., 462: 55-69, 2000.